NCT00323063 2023-03-29
Gemcitabine +/- Imatinib Mesylate, Patients w/Previously Treated Metastatic Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Terminated
Rutgers, The State University of New Jersey
University of Southampton
National Cancer Institute (NCI)
National Cancer Institute (NCI)